Evernorth, a subsidiary of Cigna, is expanding its diabetes program and will add devices and other technological resources to its traditional pharmaceutical approaches, the company said this week. The goal is to help patients better manage their diabetes.
The diabetes care value program will include coverage for continuous glucose monitors under the pharmacy benefit, which Evernorth said will provide important data on a patient’s glucose levels.
